Press Releases
April 10, 2023
HistoIndex embarks on partnership with VCU’s Stravitz-Sanyal Institute for Liver Disease and Metabolic Health in the study of liver diseases
HistoIndex embarks on partnership with VCU’s Stravitz-Sanyal Institute for Liver Disease and…
January 9, 2023
Appointment of Dr. David John Jeans CBE as HistoIndex’s Non-Executive Chairman
Appointment of Dr. David John Jeans CBE as HistoIndex’s Non-Executive Chairman …
July 29, 2022
HistoIndex Stain-free AI-DP Reveals Treatment-induced Zonal Regression of Fibrosis Colocalized with Reduction in Steatosis & Hepatocyte Ballooning in FLIGHT-FXR NASH Clinical Trial
HistoIndex Stain-free AI-DP Reveals Treatment-induced Zonal Regression of Fibrosis Colocalized with Reduction…
March 9, 2022
HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials
HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning…
October 20, 2021
HistoIndex and Galecto to Collaborate on Galecto’s Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology
HistoIndex and Galecto to Collaborate on Galecto’s Phase 2a MYLOX-1 Clinical Trial…
August 18, 2021
HistoIndex’s Stain-free AI-based Digital Pathology Incorporated as Secondary and Exploratory Efficacy Endpoints in Sagimet’s NASH FASCINATE-2 Phase 2b Clinical Trial
HistoIndex’s Stain-free AI-based Digital Pathology Incorporated as Secondary and Exploratory Efficacy Endpoints…
June 25, 2021
HistoIndex’s AI-Based Digital Pathology Indicates Concomitant Histological Improvements in Liver Fat and Fibrosis in Nonalcoholic Steatohepatitis (NASH) Patients Treated with Tropifexor Compared with Placebo
HistoIndex’s AI-Based Digital Pathology Indicates Concomitant Histological Improvements in Liver Fat and…
January 24, 2021
HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC)
HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in…
May 24, 2020
HistoIndex’s AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China
HistoIndex’s AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the…
November 9, 2019
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Histopathological Features
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and…
October 26, 2019
HistoIndex Announces Global Partnerships to Expand AI-Based Digital Pathology Platform as a Drug Discovery Tool in Preclinical Studies for Nonalcoholic Steatohepatitis (NASH)
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A…
August 20, 2019
[By Newcastle University] LITMUS – Progress towards diagnosing and better treating liver disease
LITMUS – Progress towards diagnosing and better treating liver disease –…